Antimicrobial resistance and clinical outcome of bacteroides bacteremia: Findings of a multicenter prospective observational trial

Clinical Infectious Diseases

Volumn 30, Issue 6, 2000, Pages 870-876

  Nguyen, Minh Hong ^a   Yu, Victor L ^a   Morris, Arthur J ^a   McDermott, Laura ^a   Wagener, Marilyn W ^a   Harrell, Lizzie ^a   Snydman, David R ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFOTETAN; CEFOXITIN; CLINDAMYCIN; IMIPENEM; METRONIDAZOLE; PIPERACILLIN; SULBACTAM; TIMENTIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATION; BACTEROIDES; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG SPECIFICITY; ERADICATION THERAPY; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTEROIDES; BACTEROIDES INFECTIONS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0034465384     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313805     Document Type: Article

References (20)

1. Clinical usefulness of susceptibility testing of anaerobes
2. Susceptibility testing of anaerobic bacteria
3. Susceptibility of Bacteroides fragilis group in the United States: Analysis by site of isolation
4. Present status of therapy for anaerobic infections
5. Correlation of various in vitro testing methods with clinical outcomes in patients with Bacteroides fragilis group infections treated with cefoxitin: A retrospective analysis
6. Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994
7. Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections
8. Therapeutic approaches in patients with candidemia: Evaluation in a multicenter prospective observational study
9. Antimicrobial resistance in anaerobes
10. Effect of β-lactamase inhibitors on the activities of various β-lactam agents against anaerobic bacteria
11. Epidemiology, antimicrobial susceptibility, pathogenicity, and significance of Bacteroides fragilis group organisms isolated at Los Angeles County-University of Southern California Medical Center
12. Effect of choice of medium on the results of in vitro susceptibility testing of eight antibiotics against the Bacteroides fragilis group
13. Susceptibility results for the Bacteroides fragilis group: Comparison of the broth microdilution and agar dilution methods
14. Variation in the susceptibility of Bacteroides fragilis group isolates from six Chicago hospitals
15. Multicenter study of in vitro susceptibility of the Baeteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996
16. Perforated and gangrenous appendicitis: An analysis of antibiotic failures